共 109 条
[11]
Wymer M(1996)Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators Anticancer Drugs 7 548-755
[12]
Sanna C(1987)Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extracts Jp J Cancer Res 78 748-1820
[13]
Rosso C(2007)Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med 357 1810-2011
[14]
Marietti M(1998)Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer Br J Cancer 77 2008-2596
[15]
Bugianesi E(1995)Reversible hepatic steatosis in patients treated with interferon alfa-2a and 5-fluorouracil Cancer 75 2592-727
[16]
Nishikawa M(2005)Effects of oral 5-fluorouracil drugs on hepatic fat content in patients with colon cancer Aca Radiol 12 722-956
[17]
Aosasa S(2005)Controlling tumor growth by modulating endogenous production of reactive oxygen species Cancer Res 65 948-1846
[18]
Moriya T(2010)Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis Hepatology (Baltimore, MD) 52 1836-286
[19]
Noro T(2007)Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases Br J Surg 94 274-597
[20]
Hase K(2013)Exocrine pancreatic insufficiency following esophagectomy Dis Esophagus 26 594-330